Darbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced ...

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia (wAIHA) and ...

A review of targeted therapies for anemia in patients with lower-risk myelodysplastic syndromes and myelofibrosis that improve transfusion independence and hemoglobin levels.

Anemia can be both a symptom of cancer and the result of cancer treatment. Dr. Christopher Hillis, a practicing Hamilton ...